Length of procedure (median) (range) (min) | 69.5 (16–192)a | 76 (19–194)b | .52 |
PED dimensions (median) (range) (mm) | | | |
PED length | 19 (12–35) | 20 (6–30) | .42 |
PED diameter | 4 (2.5–5.5) | 4 (3.5–5) | .26 |
Last angiographic follow-up (median) (range) (mo) | 12 (1–79)c | 18 (4.8–51)d | .008 |
Follow-up occlusion rate (No.) | | | |
Complete (100%) | 109 (75.1%)c | 62 (88.6%)d | .06 |
Near-complete (90%–99%) | 12 (8.3%) | 4 (5.7%) |
Partial (<90%) | 24 (16.6%) | 4 (5.7%) |
Retreatment (No.) | | | |
Endovascular | 7 (4.9%) | 4 (5.7%) | .81 |
Posttreatment mRS (No.) | | | |
0–2 | 169 (98.8%)e | 32 (97%)f | .42 |
3–5 | 2 (1.2%) | 1 (3%) |
Follow-up mRS (No.) | | | |
Improved | 47 (27.5%)e | 9 (27.3%)f | .33 |
No change | 112 (65.5) | 24 (72.7%) |
Worsened | 12 (7%) | 0 |
Neurologic complications (No.) | | | |
Symptomatic thromboembolic | 5 (2.7%) | 3 (8.8%) | .08 |
Permanent | 3 (1.6%) | 1 (2.9%) | .60 |
Symptomatic hemorrhagic | 2 (1.1%) | 1 (2.9%) | .39 |